Underwriting Intelligence
Milliman Underwriting Intelligence is a superior collection of data and tools designed by a focused group of experts and packaged with an unmatched level of service. IntelliScript delivers instant, accurate, and current prescription history reports. RxRules interprets medical conditions from Rx, MIB, MVR, and app data, applies your underwriting guidelines, and then generates recommendations or automated decisions all seamlessly integrated within IntelliScript. ReCheck combines prescription data and analytics to uncover potential fraud. PopulationRx uses de-identified Rx data to produce risk scores for group underwriting or in-force analyses. 1
IntelliScript A smart prescription for risk management. The Milliman IntelliScript system delivers instant, accurate, and current prescription history reports. IntelliScript gathers prescription information in real time and then lets insurers review that information in an easy-to-read online report. The result? Cost savings and fast, accurate, and effective risk assessment. More than 200 insurance companies are using IntelliScript s prescription histories. Aggregates data from health plans, pharmacy benefit managers, data clearinghouses, and retail pharmacies Delivers detailed, actionable prescription data, including prescribing physicians Customizable color-coded risk scoring Results are delivered instantly -- Directly online -- PDF imaging -- Integrated electronically into your new business system 2
RxRules Where applicant data meets powerful analytics. Milliman RxRules interprets application, Rx, MIB, and MVR data to identify potential medical conditions. The system then applies your unique underwriting guidelines to make recommendations and automated underwriting decisions. RxRules can be used out of the box or can be tailored to facilitate consistent and efficient real-time risk assessment. RxRules brings value to more than 40 insurance companies today. Fully transparent and customizable process Considers all relevant data to determine the applicant s health status Identifies medication adherence patterns Driven by mortality evidence 3
ReCheck Detecting potential fraud with data and analytics. The ReCheck system combines the power of prescription data and RxRules to identify any significant new medications that are filled immediately following an application for life insurance. Insurers use these results to investigate undisclosed pre-existing conditions. Explore ReCheck s value today. Identifies fraud early within the contestable period Avoids costly investigation and legal issues at claim time Clearly identifies specific cases to investigate 4
PopulationRx Making mortality risk assessments with confidence. PopulationRx runs a predictive model using de-identified prescription histories for a group of individuals and produces a risk score for that group. You can use PopulationRx for underwriting group life insurance and analyzing in-force blocks of business. Because the data is de-identified for PopulationRx, no authorization is required. Carriers are using the power of PopulationRx to improve their business. More accurately quote group life and disability insurance Increase your group placement rate with better risk profiles by offering more accurate and competitive rates Gain insight into the mortality of new product lines before experience becomes credible Bring medical information to guaranteed issue business 5
specializes in risk management solutions for the insurance industry. Based in Milwaukee, the IntelliScript team has been a preferred vendor to insurance carriers since 2001. If you would like to learn more, please contact: Angela Bolduc +1 617 784 8284 angela.bolduc@milliman.com rxhistories.com Milliman is among the world s largest providers of actuarial and related products and services. The firm has consulting practices in healthcare, property & casualty insurance, life insurance and financial services, and employee benefits. Founded in 1947, Milliman is an independent firm with offices in major cities around the globe. For more information, please visit milliman.com.